| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5598093 | Annals of Vascular Surgery | 2017 | 24 Pages |
Abstract
Although a randomized study is necessary, embo-EVAR may be a valid approach to prevent type II endoleaks and further complications. Mild costs and exposure-dose increase could be accepted to avoid reinterventions, and in our experience, it could be routinely performed with excellent results.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Massimiliano Natrella, Alessandro Rapellino, Federico Navarretta, Gianluca Iob, Massimo Cristoferi, Matteo Castagnola, Gianmarco Lunardi, Luca Duc, Gianluca Fanelli, Andrea Peruzzo Cornetto, Teodoro Meloni, Flavio Peinetti,